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11110-151 I Adverse Outcomes Prier to Hospital Discharge 
After Primary Stentln9 for Acute Myocardial 
Infarction Are Often Prsdlctabte, and Ralatl~l to 
Corrsctable Technical Factors 
GW. Stone, B, Om~e, J Gnffin, M -C Monte, F,S Goat, C Costant~n,, 
PA. OvodtO, J, POl~lla. WW, O'Neill, C,L, Gnnes The CaK~nsc~lar 
tnsfitt~f~, El ~tn~no Hos~t ,  Molmtain View. CA. USA 
In th~ p~" I tve  PAMI Stent Pilot Trial, sl~ntino was per fo~ in ~40 
c0n~¢uttve Ip~ w~th AMt and eJ~g~l:4o vowels at 9 ~=tea (98% ~pccess rate). 
Indepande~t ~ lab ~aph¢ ~,alysiS wa~ p e ~  (Wash, Hosp. 
Centee), As ~ repmled, in-hospital ~ve~ events w~re infrequent, 
ir~!~ng Oeath (O,l~,), remfar¢lmn (17%), te(,'urrent i~hemia (3.8%), and 
t~rget ve~..~sel mvas~lanzatmn (CABG o~ rf~PTCA. 4 6%~ ~e ~on~oslte 0f 
any 0t the~o *~ents o~-'um~! in t,5 (6-3%) pal~entS. The factor!,, prc~ctiw ut 
any adverse event after pnmary slentm9 were examines hmn Z0 chn~tll, 24 
angtog~aph~c, and ? pmoe(~ml vanal~ep, 
Rest . -  From these 51 van~,  only :2 coerelates of pre-d~scharge 
adve~ events ~ere Ide~:  stent ~ntatK~n pressure ~ t8 aim, and 
the presence of a pen-slent d~sectton grade type B by core tab analysm 
Ao~!~e events ~nt~l  m 10.4% el pts wtth stems ~mptanted at :" 18 arm., 
~a. 3.8% el pts stente~ at "- 18 arm (p < 0.05). Adverse events occuned ,n 
204% Of pts when a pen-slent ;-type B d~ssect~n was pro~nt at the end 
OI the procedure, vs. 5 ~= It no d~ssectlon was pre~tt  (p = 0.02) Ao%'erso 
events occurred in only 2.9'% Of ptS wffh nether of these 2 factom, vs. 11 5% 
with one Ol" bath (p = 0.000). AI~ other impmtant va~u~ were unrelated to 
eady adverse even~ ~ck:~.~C nt age, gender, d~abetes, LVEF, number ot 
stents implanted, slent type, use of ReoPro, reference vessel diameter, final 
MLD, and presence of lhrombua pre o~ post slenhng. 
Co~dus~t~: In-bestial ad~P3e events are infrequent after pnmary m- 
fap;l stent~ng, but am often ~ ,  and related to cowecta~e tecnn~cal 
tactms. The routine use of -- 18 arm of ~ure  to ensure complete stem ex- 
pansmn, and treatment of pen-stenl disse~ton with :~"ti~onal stems to cover 
all margin team may further *reprove the satety pmhte ot primary stenting m 
AMI 
1110-1521 Lack of  Between the Time Relationship to 
i 
Reperfus ion and Short-term Morta l i ty  Alter 
Pr imary Infarct Angioplasty 
G.W Stone, J. O'Keefe. B.R. Brodre, W.W O'Neill, CL. Gnnes EtCammo 
Hos~tal. Mountain V~ew CA, USA 
Studms of thrombolytic therapy have shown that in-hosprtal and 30 day 
mortal~j, increases as t~me to treatment is protongc~. "To explere whether 
the same relabonstup exists after pnrnary PTCA, the effect of the hme from 
symptom onset to PTCA on short-term mortality was examined by pooling 3 
large pnmary PTCA databases: 1 ) The PAMI-2 thai (982 AMI PTCAs from 
34 centers). 2) The Mid Amenca Heart Institute (2098 AMI PTCAs), and: 
3) Moses Cone Hospital (1352 AMI PTCAs). In total, primary PTCA was 
performed in 4432 pts. 284 ot whom (6%) presented in card~o~enic shock 
The mean age was 60 ± 12 yearn. 2~,  were female, and 15% had diabetes. 
Short-term mortality occurred in 6.9% of pts; 45.4% of shock pts d~d vs. 
4.2% withOut shock, p < 0.0001. Complete temporal data was available in 
4362 patients (98.4%). Time to PTCA vs. short-term mortatrty appears in the 
Table: 
.'rh'ne to PTCA (hrs) . 1 1-2 2-4 4-6 .6 p 
Non-shock pts - N 174 384 404 1189 931 - 
Mortal@ I%) 3 2°0 4 6% 3 a% 46% 4 5% o 77 
Shock pts - N 9 30 77 88 76 - 
k~ona~ °.~ 22 2=o 4t 9% 462=0 461% 467% O 69 
The mean time from symptom onset to PTCA in non-shock patients who 
died vs. survived was 311 • 264 vs. 327 • 192 rains, p = 0.77, and in shock 
pts 319 ± 286 vs. 336 ± 305 rams, p = 0.54. In the most detailed database 
(PAMI-2), the only independent predictors of survival by multivariate analysis 
were young age, absence of 3VD, and establishment of TIMI-3 flow after 
PTCA. which was achieved in 93% of pts, independent of time to angioplssty. 
Conclusions: These data suggest that whereas reperfusion by PTCA 
within 1 hour of symptom onset (possible in 4% of pts) may pussibly improve 
eady survival, mortality after 1 hour does not increase with delayed reporfu- 
sion, attesting to the fundamental importance of the open infarct artery for a 
favorable early prognosis. 
• AxlIII Plaque Redl~rlbutlon In Coronary 
Stentlng: Implication= for Reference ~h~lmem 
Measurements, 
Jonas A Metz, Frank Womer, Kafl-He~r~ t~enneke, Andre~s K0~g, 
Voltor Kl~u*3s, Kad Thomson, Haral~ Mt~ra IVleo~! t '~ l .  Un~er,~. at 
Mumch, Germany 
~gmu~.  Recent slg(te~ empl~,~ng intrav~ular t~f~ (IVUS) h#ve 
~hOWl~ that Pa!loof, ang~plas~ ia chara(~en~ed by ~ial pl~lu~ i ~ f l ~  
t~ the to=on one to the ad~a,cenl artery s~9~.  In ~'or,,ary ~]~ntmg, 
1hit mechanism m;~y iftlp~t f l i~r~l~ ~ al~ felat~v~  e l~)n~ 
ca~cu~atm~ a~ we,I M ~ ~ of i n~ow ( ~  at ~emt ~ .  We 
detownme~ the change in reference ~ n t  plaque area fodowlng coronary 
stentm~ (pce/pOSl), 
/ t~:  From our datab~,e, 20 ~nted  patients wefo =seleCted ~ n 9  
to the k~lowing cntena: Pre. alxt pos l . in le ree~!  IVU~ imagm~ p e ~  
w~th a ny.~l~,ized ptlllbRck (~vK~e, 10 patients wltho~ IVUS siges ot ca~Th- 
catmn, 10 pahents wllh cak~ffied lesions (~. ~,  ~ I ~m lenglh) Standam 
IVUS parametem were measgre0 *n correspo~JIng (pre~ost) crose,~echo~s 
m the reference segments (t-3 mm from the stent edge) to calculate the 
change (gest-pre) in plaque area (PA). Mean lesion PA and lesmn length 
before interventmn were measured for calculation ot a plaque volume lP,~e= 
Pr= Pt~t 
-"~ I " ...... ' 
: ~ o 
Result. A 1.18 mm 2 (20.65)-increase in average reference PA was seen 
upon the final IVUS pullback, independent of the presence el calcium or 
degree of premten,'erltional lesion plaque load. 
C..~":~...us/~n. There is a sig~fic3m ptaqua redistnbution to the reference 
segments impacting reference segment anatysm. 
Role of Inflammation and Stress in Coronary 
Disease  
Tuesday,  March 31, 1998, Noon-2 :00  p.m. 
Georg ia  Wodd Congress  Center,  West Exhibit Hall Level  
P resentat ion  Hour. 1:00 p . rn . -2 :00  p.m. 
1111 131 I Low of  Detectable Human Frequency 
Cytomegalovirus DNA in Coronary 
Atherosclerotio Les ions Obtained by Coronary 
Endatherectomy 
PW Radke ~ . S. Me~elbach 2. H D6rge 3, F Sct~ndubc 3, M. Vo~ ~, 
PK. Haager I . H.G. Klues ~ , B.J. Messme~, S, Hanoi, P. Hanmth ~ .
' Medical Chmc I Germany: :lnsl~tute of Pathology Germany; ~Department 
ot Cardiot~oraclc Surgery. RWTH Aachen, Germany 
Background. Cytomegafowrus (CMV) infechon has been implicated m the 
development o1 athemsderosrs and rester, osis after coronary angmptasty, 
Previous stedms demonstrated CMV in coronary specimen obtained by di. 
rectional coronary atherectorny (DCA) and were limited to small sample sizes 
possibly undemsbmating the frequency of CMV-DNA within atherasclemtic 
l~Jons. 
Methods: The presence of CMV-DNA in pnmary coronary lesions was 
assessed m coronary endatheredorny spe~men obtained dunng suCceSS- 
ful aortocoronary bypass (ACB) surgery in 28 patients (23 men..5 women. 
mean age 62 ± 9 ym) with severn coronay artery disease (CAD). DNA from 
large coronary samples (5-30 mm long) was extracted uSi.,'cj the QIA~TiG - 
sue-Kit (QIAGEN, Germany). Amplification of CMV target DNA sequences 
was corned out by using Taq polymerase (Boehnnger. Germany). The PCR 
products were further specified by a novel liquid hybndisatron assay called 
PCR-enzyme-Ilnked immunosorbent assay 
Results: Positive PCR for CMV-DNA was found in 2/26 samples (7%) 
from coronary endatherectorny ,,;amples obtained dunng ACB surgery. Addi- 
tional PCR-enzyme-linked immunasorbent assay specified all PCR-positive 
samples. 
Conclusions: The low frequency of detectable human ¢ytomegalovirus 
DNA in coronary atherosclerotic lesions (7%/does not support he hypothesis 
that a latent CMV infection of coronary arteries is a major pathogenetio factor 
for the development of CAD. 
